D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Gran Tierra Energy
GTE
$357M
| $7.24M | ﹤0.01% |
1,158,224
+58,018
| +5% | +$474K |
|
2002
Wabtec
WAB
$47.8B
| $7.23M | ﹤0.01% |
26,822
+1,979
| +8% | +$523K |
|
|
GSRF
2003
GSR IV Acquisition Corp
GSRF
$301M
| $7.22M | ﹤0.01% |
710,272
| – | – |
|
2004
Brady Corp
BRC
$4.23B
| $7.22M | ﹤0.01% |
78,803
+63,908
| +429% | +$5.31M |
|
2005
CALL
Liquidia Corp
LQDA
$6.15B
| $7.22M | ﹤0.01% |
90,500
+54,300
| +150% | +$2.91M |
|
|
EVOX
2006
Evolution Global Acquisition Corp
EVOX
$324M
| $7.21M | ﹤0.01% |
719,997
| – | – |
|
2007
CALL
HCA Healthcare
HCA
$87.7B
| $7.21M | ﹤0.01% |
18,500
+5,200
| +39% | +$2.2M |
|
|
TVA
2008
Texas Ventures Acquisition III Corp
TVA
$316M
| $7.18M | ﹤0.01% |
681,000
+1,000
| +0.1% | +$10.5K |
|
|
TEN
2009
Tsakos Energy Navigation Ltd
TEN
$1.32B
| $7.18M | ﹤0.01% |
203,062
-142,210
| -41% | -$5.66M |
|
2010
Mirion Technologies
MIR
$4.12B
| $7.18M | ﹤0.01% |
400,454
-67,683
| -14% | -$1.26M |
|
2011
BBVA Argentina
BBAR
$3.03B
| $7.17M | ﹤0.01% |
365,858
-20,496
| -5% | -$345K |
|
|
AYA
2012
Aya Gold & Silver Inc
AYA
$4.16B
| $7.17M | ﹤0.01% |
+379,100
| New | +$7.17M |
|
|
UPB
2013
Upstream Bio Inc
UPB
$329M
| $7.17M | ﹤0.01% |
1,036,044
+215,564
| +26% | +$1.81M |
|
2014
Charles River Laboratories
CRL
$13.8B
| $7.16M | ﹤0.01% |
31,587
-161,896
| -84% | -$28.8M |
|
2015
Constellation Brands
STZ
$21.9B
| $7.16M | ﹤0.01% |
51,453
+23,875
| +87% | +$3.55M |
|
2016
PUT
Enphase Energy
ENPH
$4.81B
| $7.13M | ﹤0.01% |
144,900
-280,100
| -66% | -$12.8M |
|
2017
Radian Group
RDN
$4.85B
| $7.13M | ﹤0.01% |
189,381
-262,574
| -58% | -$9.32M |
|
2018
Camden Property Trust
CPT
$12.2B
| $7.13M | ﹤0.01% |
62,301
+14,844
| +31% | +$1.58M |
|
|
PDS
2019
Precision Drilling
PDS
$1.16B
| $7.12M | ﹤0.01% |
92,865
-34,068
| -27% | -$3.11M |
|
2020
CALL
Fluence Energy
FLNC
$1.48B
| $7.12M | ﹤0.01% |
357,900
-86,400
| -19% | -$1.61M |
|
|
MZYX
2021
MOZAYYX Acquisition Corp
MZYX
$375M
| $7.1M | ﹤0.01% |
+711,898
| New | +$7.05M |
|
2022
CALL
Fluor
FLR
$7.51B
| $7.07M | ﹤0.01% |
135,000
| – | – |
|
2023
Fortis
FTS
$28.2B
| $7.07M | ﹤0.01% |
123,572
-25,550
| -17% | -$1.44M |
|
2024
HighPeak Energy
HPK
$1.02B
| $7.07M | ﹤0.01% |
1,011,449
+268,791
| +36% | +$1.85M |
|
2025
Pacific Biosciences
PACB
$420M
| $7.07M | ﹤0.01% |
4,208,146
+570,599
| +16% | +$830K |
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.